4PIV | Human Fatty Acid Synthase Psi/KR Tri-Domain with NADPH and GSK2194069 | date | |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Williams, S.P., Wang, L., Brown, K.K., Parrish, C.A., Hardwicke, M.A. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.30 | ||||||||||||
ligand | 2W4, CAC, NDP, SO4 | enzyme |
| ||||||||||||
Primary reference | A human fatty acid synthase inhibitor binds beta-ketoacyl reductase in the keto-substrate site., Hardwicke MA, Rendina AR, Williams SP, Moore ML, Wang L, Krueger JA, Plant RN, Totoritis RD, Zhang G, Briand J, Burkhart WA, Brown KK, Parrish CA, Nat Chem Biol. 2014 Sep;10(9):774-9. doi: 10.1038/nchembio.1603. Epub 2014 Aug 3. PMID:25086508 |
Data retrieval |
View 4PIV in 3D |
Visual 3D analysis of 4PIV |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4PIV |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |